Evaluation of the Incidence, Severity, and Mortality Rate of COVID-19 in Patients with Multiple Sclerosis Receiving Interferon β-1a

Authors

  • Abdorreza Naser Moghadasi
  • Nassim Anjidani

DOI:

https://doi.org/10.18502/fem.v5i2.5607

Abstract

The article's abstract is not available.

Downloads

Published

2021-03-02

Issue

Volume 5 issue (2)

Section

Articles